![glp-1 antibody GLP1 (4) [Alexa Fluor® 488] (NBP2-23558AF488) by Novus, Part of Bio-Techne Immunogen corresponding to Synthetic HPLC Verified GLP-1 Agonists: Increasing Effective Option:3 Month Supply (Bundled)](https://resources.rndsystems.com/categoryimages/novus_antibodies.jpg)
![glp-1 antibody GLP1 (4) [Alexa Fluor® 488] (NBP2-23558AF488) by Novus, Part of Bio-Techne Immunogen corresponding to Synthetic HPLC Verified GLP-1 Agonists: Increasing Effective Option:3 Month Supply (Bundled)](https://i0.wp.com/calmatters.org/wp-content/uploads/2025/05/070123_Ozempic_AP_CM_01.jpg?fit=1200%2C800&ssl=1)
![glp-1 antibody GLP1 (4) [Alexa Fluor® 488] (NBP2-23558AF488) by Novus, Part of Bio-Techne Immunogen corresponding to Synthetic HPLC Verified GLP-1 Agonists: Increasing Effective Option:3 Month Supply (Bundled)](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3860843433112368343)
![glp-1 antibody GLP1 (4) [Alexa Fluor® 488] (NBP2-23558AF488) by Novus, Part of Bio-Techne Immunogen corresponding to Synthetic HPLC Verified GLP-1 Agonists: Increasing Effective Option:3 Month Supply (Bundled)](https://healthexec.com/sites/default/files/2022-05/tirzepatide_mounjaro_eli_lilly.jpg)
Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
glp-1 antibody GLP1 (4) [Alexa Fluor® 488] (NBP2-23558AF488) by Novus, Part of Bio-Techne Immunogen corresponding to Synthetic HPLC Verified GLP-1 Agonists: Increasing Effective Option:3 Month Supply (Bundled)
GLP-1 Agonists: Increasing Effective Insulin Release
Abstract Nonalcoholic fatty liver disease (NAFLD) can lead to liver fibrosis and cirrhosis
HPLC Verified
Option:3 Month Supply (Bundled)
10.1111/obr.12551
Immunogen corresponding to Synthetic Peptide within Human GCG aa 50
US$ 27.58
US$ 27.21
US$ 23.97
US$ 25.59
